Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
RNA-Binding Protein EWS | 11 | 2024 | 211 | 2.210 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 5 | 2023 | 104 | 1.810 |
Why?
|
Oncogene Proteins, Fusion | 14 | 2024 | 1609 | 1.540 |
Why?
|
Wilms Tumor | 7 | 2024 | 378 | 1.160 |
Why?
|
Chromatin | 13 | 2024 | 2980 | 1.140 |
Why?
|
In Situ Hybridization | 12 | 2021 | 1885 | 0.880 |
Why?
|
Gene Expression Regulation, Neoplastic | 21 | 2024 | 8613 | 0.810 |
Why?
|
Bone Neoplasms | 6 | 2021 | 2559 | 0.730 |
Why?
|
Tumor Suppressor Proteins | 10 | 2016 | 2793 | 0.720 |
Why?
|
Karyopherins | 2 | 2024 | 133 | 0.690 |
Why?
|
Microsatellite Repeats | 2 | 2018 | 784 | 0.640 |
Why?
|
Gene Silencing | 2 | 2018 | 1505 | 0.560 |
Why?
|
Odontogenic Tumors | 3 | 2024 | 48 | 0.560 |
Why?
|
Calmodulin-Binding Proteins | 2 | 2019 | 237 | 0.560 |
Why?
|
Otx Transcription Factors | 1 | 2017 | 42 | 0.550 |
Why?
|
Enhancer Elements, Genetic | 3 | 2018 | 1363 | 0.540 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2024 | 853 | 0.530 |
Why?
|
Chromatin Assembly and Disassembly | 4 | 2020 | 631 | 0.520 |
Why?
|
Genes, Wilms Tumor | 2 | 2007 | 92 | 0.520 |
Why?
|
WT1 Proteins | 4 | 2024 | 182 | 0.520 |
Why?
|
Medulloblastoma | 2 | 2019 | 657 | 0.500 |
Why?
|
Adenocarcinoma, Clear Cell | 3 | 2021 | 218 | 0.480 |
Why?
|
RNA-Binding Proteins | 3 | 2020 | 1883 | 0.470 |
Why?
|
Salivary Gland Neoplasms | 3 | 2024 | 306 | 0.460 |
Why?
|
Ventricular Remodeling | 2 | 2019 | 1276 | 0.460 |
Why?
|
Myocardial Contraction | 1 | 2019 | 1516 | 0.460 |
Why?
|
Hepatoblastoma | 1 | 2013 | 90 | 0.420 |
Why?
|
DNA | 5 | 2023 | 7192 | 0.420 |
Why?
|
Sirtuins | 3 | 2022 | 323 | 0.420 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2013 | 97 | 0.410 |
Why?
|
Sarcoma, Clear Cell | 2 | 2024 | 73 | 0.410 |
Why?
|
RNA, Small Interfering | 5 | 2019 | 3423 | 0.410 |
Why?
|
Cell Line, Tumor | 27 | 2024 | 17071 | 0.400 |
Why?
|
Cerebellar Neoplasms | 1 | 2017 | 570 | 0.390 |
Why?
|
Adaptor Proteins, Signal Transducing | 9 | 2015 | 2898 | 0.380 |
Why?
|
Transcription, Genetic | 6 | 2022 | 7599 | 0.360 |
Why?
|
Myocardium | 3 | 2019 | 4765 | 0.360 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2024 | 431 | 0.340 |
Why?
|
Sarcoma, Synovial | 2 | 2021 | 157 | 0.320 |
Why?
|
Chromosomes, Human, X | 2 | 2007 | 319 | 0.300 |
Why?
|
Myocardial Ischemia | 2 | 2015 | 2130 | 0.290 |
Why?
|
Kidney Neoplasms | 5 | 2024 | 4282 | 0.280 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 3926 | 0.270 |
Why?
|
Protein Isoforms | 4 | 2024 | 1715 | 0.260 |
Why?
|
Mesenchymal Stem Cells | 4 | 2018 | 1663 | 0.250 |
Why?
|
Wnt Proteins | 3 | 2016 | 721 | 0.240 |
Why?
|
Spheroids, Cellular | 2 | 2024 | 328 | 0.240 |
Why?
|
Transcription Factors | 9 | 2022 | 12128 | 0.230 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2024 | 33 | 0.230 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2023 | 453 | 0.230 |
Why?
|
Gene Expression Profiling | 5 | 2020 | 9525 | 0.230 |
Why?
|
Antigens, Nuclear | 2 | 2015 | 182 | 0.230 |
Why?
|
SOXB1 Transcription Factors | 2 | 2016 | 283 | 0.220 |
Why?
|
Liver Neoplasms | 3 | 2015 | 4354 | 0.220 |
Why?
|
Neoplastic Stem Cells | 4 | 2017 | 1351 | 0.220 |
Why?
|
Sequence Analysis, RNA | 6 | 2017 | 2039 | 0.220 |
Why?
|
Gene Deletion | 5 | 2018 | 2667 | 0.210 |
Why?
|
Multiprotein Complexes | 4 | 2020 | 1107 | 0.210 |
Why?
|
Soft Tissue Neoplasms | 2 | 2022 | 1163 | 0.210 |
Why?
|
Cardiomyopathies | 1 | 2015 | 2061 | 0.200 |
Why?
|
Cyclin D1 | 1 | 2024 | 449 | 0.200 |
Why?
|
Hydrazines | 1 | 2024 | 223 | 0.200 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2022 | 222 | 0.190 |
Why?
|
Pharmacy | 1 | 2023 | 92 | 0.190 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2022 | 91 | 0.190 |
Why?
|
RNA, Untranslated | 2 | 2018 | 454 | 0.190 |
Why?
|
Adenocarcinoma | 5 | 2020 | 6361 | 0.190 |
Why?
|
Salivary Glands | 2 | 2021 | 231 | 0.190 |
Why?
|
Cell Transformation, Neoplastic | 6 | 2023 | 2838 | 0.180 |
Why?
|
Single-Cell Analysis | 5 | 2021 | 2535 | 0.180 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2017 | 1138 | 0.180 |
Why?
|
Epigenesis, Genetic | 5 | 2020 | 3821 | 0.180 |
Why?
|
Interferons | 2 | 2022 | 714 | 0.170 |
Why?
|
Kidney | 5 | 2010 | 7072 | 0.170 |
Why?
|
Nuclear Proteins | 4 | 2022 | 5791 | 0.170 |
Why?
|
RNA, Viral | 2 | 2021 | 2868 | 0.170 |
Why?
|
Animals | 36 | 2024 | 168801 | 0.170 |
Why?
|
Fibrillar Collagens | 1 | 2019 | 42 | 0.170 |
Why?
|
Humans | 79 | 2024 | 766019 | 0.160 |
Why?
|
Cysteine | 1 | 2024 | 898 | 0.160 |
Why?
|
Mice | 29 | 2024 | 81838 | 0.160 |
Why?
|
DNA-Binding Proteins | 6 | 2022 | 9600 | 0.160 |
Why?
|
Cell Survival | 4 | 2017 | 5744 | 0.160 |
Why?
|
Retinoblastoma Protein | 1 | 2022 | 666 | 0.160 |
Why?
|
Jaw Neoplasms | 1 | 2019 | 71 | 0.160 |
Why?
|
Myocardial Infarction | 1 | 2019 | 11506 | 0.150 |
Why?
|
Aniline Compounds | 2 | 2015 | 1078 | 0.150 |
Why?
|
Triazoles | 1 | 2024 | 902 | 0.150 |
Why?
|
Retroperitoneal Space | 1 | 2019 | 175 | 0.150 |
Why?
|
Mandibular Neoplasms | 1 | 2019 | 131 | 0.150 |
Why?
|
Skull Neoplasms | 1 | 2019 | 173 | 0.150 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2019 | 119 | 0.150 |
Why?
|
Neoplasms | 7 | 2024 | 22336 | 0.150 |
Why?
|
Viral Vaccines | 1 | 2003 | 596 | 0.150 |
Why?
|
Facial Bones | 1 | 2019 | 209 | 0.150 |
Why?
|
Melanoma, Experimental | 1 | 2021 | 555 | 0.150 |
Why?
|
DNA Contamination | 1 | 2017 | 18 | 0.140 |
Why?
|
Pancreatic Neoplasms | 4 | 2019 | 5454 | 0.140 |
Why?
|
Proto-Oncogene Proteins | 6 | 2018 | 4520 | 0.140 |
Why?
|
RANK Ligand | 1 | 2019 | 321 | 0.140 |
Why?
|
Lung Neoplasms | 6 | 2023 | 13483 | 0.140 |
Why?
|
Tumor Cells, Cultured | 4 | 2018 | 6101 | 0.140 |
Why?
|
Papillomaviridae | 1 | 2003 | 1137 | 0.140 |
Why?
|
Dystrophin | 1 | 2018 | 283 | 0.140 |
Why?
|
Prolactin | 1 | 2019 | 626 | 0.140 |
Why?
|
Immunohistochemistry | 6 | 2021 | 11035 | 0.140 |
Why?
|
Barrett Esophagus | 1 | 2020 | 494 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 361 | 0.130 |
Why?
|
Stromal Cells | 2 | 2019 | 1332 | 0.130 |
Why?
|
Apoptosis | 7 | 2024 | 9507 | 0.130 |
Why?
|
Gene Rearrangement | 2 | 2019 | 1142 | 0.130 |
Why?
|
Liposarcoma | 1 | 2019 | 288 | 0.130 |
Why?
|
Protein Binding | 5 | 2020 | 9302 | 0.130 |
Why?
|
Neuroblastoma | 1 | 2024 | 1263 | 0.130 |
Why?
|
Repressor Proteins | 3 | 2016 | 2974 | 0.130 |
Why?
|
In Situ Hybridization, Fluorescence | 5 | 2021 | 2510 | 0.130 |
Why?
|
Gene Expression Regulation | 5 | 2016 | 11906 | 0.130 |
Why?
|
Apoptosis Regulatory Proteins | 4 | 2015 | 1150 | 0.130 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2016 | 182 | 0.130 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2015 | 84 | 0.120 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2020 | 1245 | 0.120 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2015 | 26 | 0.120 |
Why?
|
Fibrosis | 2 | 2019 | 2073 | 0.120 |
Why?
|
Principal Component Analysis | 2 | 2017 | 948 | 0.120 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2015 | 171 | 0.120 |
Why?
|
RNA Interference | 3 | 2019 | 2825 | 0.120 |
Why?
|
Azacitidine | 1 | 2017 | 335 | 0.120 |
Why?
|
Oligodendroglioma | 1 | 2016 | 274 | 0.120 |
Why?
|
Point Mutation | 3 | 2016 | 1591 | 0.120 |
Why?
|
Human papillomavirus 18 | 1 | 2015 | 125 | 0.120 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2017 | 780 | 0.120 |
Why?
|
Tumor Microenvironment | 2 | 2019 | 3942 | 0.120 |
Why?
|
Cancer Vaccines | 1 | 2022 | 1042 | 0.120 |
Why?
|
Sulfonamides | 2 | 2015 | 1980 | 0.120 |
Why?
|
Mice, Inbred NOD | 2 | 2019 | 1836 | 0.120 |
Why?
|
Morpholines | 2 | 2015 | 584 | 0.110 |
Why?
|
Isocitrate Dehydrogenase | 2 | 2017 | 955 | 0.110 |
Why?
|
Sequence Analysis, DNA | 2 | 2023 | 4779 | 0.110 |
Why?
|
Cell Lineage | 3 | 2019 | 2574 | 0.110 |
Why?
|
Human papillomavirus 16 | 1 | 2015 | 268 | 0.110 |
Why?
|
Mice, SCID | 2 | 2019 | 2625 | 0.110 |
Why?
|
Cell Differentiation | 9 | 2023 | 11642 | 0.110 |
Why?
|
beta Catenin | 2 | 2010 | 1047 | 0.110 |
Why?
|
Leukemia, Myeloid | 1 | 2016 | 695 | 0.110 |
Why?
|
Serine Endopeptidases | 1 | 2018 | 1027 | 0.110 |
Why?
|
Carcinoma | 1 | 2024 | 2313 | 0.100 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2013 | 182 | 0.100 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2022 | 2945 | 0.100 |
Why?
|
Pyridines | 1 | 2024 | 2889 | 0.100 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2013 | 271 | 0.100 |
Why?
|
RNA, Messenger | 7 | 2018 | 12772 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2015 | 2328 | 0.100 |
Why?
|
Promoter Regions, Genetic | 4 | 2022 | 5784 | 0.100 |
Why?
|
Lung | 2 | 2021 | 10061 | 0.100 |
Why?
|
Albumins | 1 | 2014 | 578 | 0.100 |
Why?
|
Zebrafish Proteins | 1 | 2018 | 1017 | 0.100 |
Why?
|
Antigen Presentation | 3 | 2002 | 1250 | 0.100 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3664 | 0.100 |
Why?
|
Serum Albumin | 1 | 2015 | 674 | 0.090 |
Why?
|
Female | 35 | 2024 | 396174 | 0.090 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2003 | 2039 | 0.090 |
Why?
|
Introns | 1 | 2013 | 965 | 0.090 |
Why?
|
p300-CBP Transcription Factors | 1 | 2012 | 147 | 0.090 |
Why?
|
DNA, Satellite | 1 | 2011 | 67 | 0.090 |
Why?
|
Rats, Sprague-Dawley | 2 | 2019 | 8114 | 0.090 |
Why?
|
Male | 28 | 2021 | 363880 | 0.090 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2010 | 0.090 |
Why?
|
Autoantigens | 1 | 2015 | 886 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 614 | 0.090 |
Why?
|
Calcium-Binding Proteins | 1 | 2015 | 1077 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2020 | 1659 | 0.090 |
Why?
|
Protein Kinase Inhibitors | 3 | 2013 | 5695 | 0.090 |
Why?
|
Trans-Activators | 2 | 2022 | 2849 | 0.090 |
Why?
|
Sarcoma | 1 | 2021 | 1801 | 0.090 |
Why?
|
Receptors, Androgen | 1 | 2016 | 1088 | 0.080 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2019 | 1762 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 2023 | 313 | 0.080 |
Why?
|
Meningioma | 1 | 2018 | 1221 | 0.080 |
Why?
|
Radiology | 1 | 2023 | 2105 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2825 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2024 | 3605 | 0.080 |
Why?
|
Translocation, Genetic | 2 | 2022 | 1392 | 0.080 |
Why?
|
Sequence Deletion | 1 | 2013 | 1494 | 0.080 |
Why?
|
Membrane Proteins | 5 | 2015 | 7850 | 0.080 |
Why?
|
Genomics | 3 | 2019 | 5924 | 0.080 |
Why?
|
Meningeal Neoplasms | 1 | 2018 | 1252 | 0.080 |
Why?
|
Cholangiocarcinoma | 1 | 2014 | 577 | 0.080 |
Why?
|
Bile Duct Neoplasms | 1 | 2014 | 624 | 0.080 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2429 | 0.080 |
Why?
|
Oncogenes | 3 | 2022 | 1231 | 0.080 |
Why?
|
Lymphoma, B-Cell | 1 | 2015 | 943 | 0.080 |
Why?
|
Lectins, C-Type | 2 | 2002 | 592 | 0.080 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6961 | 0.080 |
Why?
|
Signal Transduction | 6 | 2024 | 23600 | 0.080 |
Why?
|
Mice, Nude | 5 | 2013 | 3610 | 0.070 |
Why?
|
RNA, Neoplasm | 1 | 2011 | 744 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2015 | 2056 | 0.070 |
Why?
|
Binding Sites | 3 | 2023 | 6002 | 0.070 |
Why?
|
Chromosome Deletion | 2 | 2016 | 1384 | 0.070 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2014 | 949 | 0.070 |
Why?
|
Metabolic Networks and Pathways | 1 | 2012 | 799 | 0.070 |
Why?
|
Forkhead Transcription Factors | 1 | 2015 | 1623 | 0.070 |
Why?
|
Cell Cycle Proteins | 4 | 2024 | 3436 | 0.070 |
Why?
|
Base Sequence | 2 | 2016 | 12405 | 0.070 |
Why?
|
Colonic Neoplasms | 2 | 2017 | 2532 | 0.070 |
Why?
|
Transfection | 2 | 2019 | 5739 | 0.070 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2007 | 247 | 0.070 |
Why?
|
Prostatic Neoplasms | 3 | 2019 | 11092 | 0.070 |
Why?
|
Cells, Cultured | 3 | 2018 | 18965 | 0.070 |
Why?
|
Extracellular Matrix | 1 | 2014 | 1727 | 0.070 |
Why?
|
Collagen | 1 | 2015 | 2618 | 0.070 |
Why?
|
HEK293 Cells | 4 | 2019 | 4262 | 0.070 |
Why?
|
DNA Methylation | 3 | 2017 | 4426 | 0.070 |
Why?
|
Antineoplastic Agents | 3 | 2020 | 13635 | 0.070 |
Why?
|
Cell Line | 3 | 2013 | 15545 | 0.070 |
Why?
|
Glycoproteins | 2 | 2016 | 2197 | 0.070 |
Why?
|
Melanoma | 2 | 2024 | 5695 | 0.070 |
Why?
|
Myocytes, Cardiac | 1 | 2015 | 1674 | 0.070 |
Why?
|
Dendritic Cells | 3 | 2002 | 2747 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2013 | 1656 | 0.060 |
Why?
|
Stomach Neoplasms | 1 | 2016 | 1471 | 0.060 |
Why?
|
Biopsy | 4 | 2020 | 6768 | 0.060 |
Why?
|
Disease Models, Animal | 4 | 2019 | 18321 | 0.060 |
Why?
|
Adenoma | 1 | 2016 | 2155 | 0.060 |
Why?
|
Cell Proliferation | 5 | 2020 | 10431 | 0.060 |
Why?
|
RNA | 3 | 2022 | 2715 | 0.060 |
Why?
|
Breast Neoplasms | 3 | 2023 | 21072 | 0.060 |
Why?
|
Nerve Tissue Proteins | 2 | 2015 | 4399 | 0.060 |
Why?
|
Intestinal Mucosa | 1 | 2016 | 3048 | 0.060 |
Why?
|
Child | 10 | 2023 | 80567 | 0.060 |
Why?
|
Child, Preschool | 5 | 2019 | 42509 | 0.060 |
Why?
|
Automation, Laboratory | 2 | 2015 | 102 | 0.060 |
Why?
|
Adult | 13 | 2021 | 223110 | 0.060 |
Why?
|
Protein Stability | 2 | 2020 | 576 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5388 | 0.060 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 2 | 2016 | 85 | 0.060 |
Why?
|
Workflow | 2 | 2022 | 859 | 0.060 |
Why?
|
Middle Aged | 15 | 2021 | 223035 | 0.060 |
Why?
|
Fatty Acids | 1 | 2012 | 1806 | 0.060 |
Why?
|
Brain Neoplasms | 2 | 2017 | 9064 | 0.060 |
Why?
|
SOXE Transcription Factors | 1 | 2024 | 74 | 0.060 |
Why?
|
Glioblastoma | 3 | 2014 | 3457 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2013 | 2425 | 0.050 |
Why?
|
Papillomavirus Infections | 1 | 2015 | 1637 | 0.050 |
Why?
|
Aged | 12 | 2021 | 171170 | 0.050 |
Why?
|
Head and Neck Neoplasms | 2 | 2015 | 2926 | 0.050 |
Why?
|
Stem Cells | 1 | 2016 | 3537 | 0.050 |
Why?
|
Organoids | 2 | 2020 | 741 | 0.050 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2006 | 496 | 0.050 |
Why?
|
Databases, Bibliographic | 1 | 2003 | 128 | 0.050 |
Why?
|
Carrier Proteins | 3 | 2014 | 4910 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2015 | 4047 | 0.050 |
Why?
|
Genes, BRCA1 | 1 | 2006 | 753 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4783 | 0.050 |
Why?
|
E2F1 Transcription Factor | 1 | 2022 | 182 | 0.050 |
Why?
|
Neoplasm Proteins | 2 | 2013 | 3594 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2006 | 562 | 0.050 |
Why?
|
E2F Transcription Factors | 1 | 2022 | 269 | 0.050 |
Why?
|
Glioma | 1 | 2017 | 3492 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2021 | 15403 | 0.050 |
Why?
|
Prognosis | 3 | 2019 | 29905 | 0.050 |
Why?
|
Cell Nucleolus | 1 | 2022 | 156 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5836 | 0.050 |
Why?
|
Life Cycle Stages | 1 | 2022 | 161 | 0.050 |
Why?
|
Epigenomics | 2 | 2020 | 959 | 0.050 |
Why?
|
Acetylation | 2 | 2016 | 1054 | 0.050 |
Why?
|
Gene Expression | 4 | 2011 | 7581 | 0.050 |
Why?
|
RNA, Ribosomal | 1 | 2022 | 227 | 0.050 |
Why?
|
Mutation | 6 | 2023 | 30210 | 0.050 |
Why?
|
Transcription Factor AP-1 | 1 | 2022 | 321 | 0.040 |
Why?
|
Lamivudine | 1 | 2022 | 368 | 0.040 |
Why?
|
Intestines | 2 | 2022 | 1904 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2010 | 13400 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2018 | 9540 | 0.040 |
Why?
|
Gene Regulatory Networks | 2 | 2024 | 1750 | 0.040 |
Why?
|
Surface-Active Agents | 1 | 2020 | 150 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2023 | 5334 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2879 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2015 | 702 | 0.040 |
Why?
|
Heterozygote | 1 | 2007 | 2796 | 0.040 |
Why?
|
Medical Oncology | 2 | 2022 | 2339 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 4565 | 0.040 |
Why?
|
Molecular Sequence Data | 3 | 2010 | 17597 | 0.040 |
Why?
|
Heart Failure | 2 | 2015 | 11816 | 0.040 |
Why?
|
Phlebitis | 1 | 2019 | 34 | 0.040 |
Why?
|
DNA Copy Number Variations | 2 | 2019 | 2043 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 2 | 2016 | 1058 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2024 | 9378 | 0.040 |
Why?
|
Retinoid X Receptors | 1 | 2019 | 91 | 0.040 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2020 | 308 | 0.040 |
Why?
|
Calcium | 1 | 2012 | 5770 | 0.040 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2019 | 66 | 0.040 |
Why?
|
Alleles | 2 | 2007 | 6892 | 0.040 |
Why?
|
Sex Chromatin | 1 | 2018 | 19 | 0.040 |
Why?
|
Esophagoscopy | 1 | 2020 | 398 | 0.040 |
Why?
|
Estrogen Receptor alpha | 1 | 2023 | 580 | 0.040 |
Why?
|
Adenovirus E1A Proteins | 1 | 2018 | 81 | 0.040 |
Why?
|
Integrins | 1 | 2023 | 838 | 0.040 |
Why?
|
Histones | 2 | 2020 | 2591 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2020 | 59497 | 0.040 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2021 | 2054 | 0.040 |
Why?
|
RNA Stability | 1 | 2020 | 319 | 0.040 |
Why?
|
Oxidation-Reduction | 1 | 2024 | 2223 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2002 | 4649 | 0.040 |
Why?
|
Immunoblotting | 2 | 2012 | 1644 | 0.040 |
Why?
|
Glycolysis | 1 | 2022 | 837 | 0.040 |
Why?
|
RNA Polymerase II | 1 | 2022 | 549 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3787 | 0.040 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2022 | 604 | 0.040 |
Why?
|
Mucins | 1 | 2020 | 567 | 0.040 |
Why?
|
Phosphoproteins | 2 | 2021 | 2445 | 0.040 |
Why?
|
DNA, Neoplasm | 2 | 2014 | 1739 | 0.040 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2010 | 856 | 0.040 |
Why?
|
Doxorubicin | 1 | 2024 | 2226 | 0.040 |
Why?
|
NIH 3T3 Cells | 2 | 2010 | 651 | 0.030 |
Why?
|
Antigens | 1 | 2002 | 1437 | 0.030 |
Why?
|
Th1 Cells | 1 | 2022 | 1041 | 0.030 |
Why?
|
Ligands | 1 | 2024 | 3274 | 0.030 |
Why?
|
Mice, Inbred C57BL | 5 | 2010 | 22339 | 0.030 |
Why?
|
Mice, Knockout | 5 | 2016 | 14457 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2021 | 561 | 0.030 |
Why?
|
Autopsy | 1 | 2020 | 1011 | 0.030 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2019 | 319 | 0.030 |
Why?
|
Liposomes | 1 | 2000 | 786 | 0.030 |
Why?
|
Th2 Cells | 1 | 2022 | 1074 | 0.030 |
Why?
|
Mucin-2 | 1 | 2016 | 50 | 0.030 |
Why?
|
Epithelial Cells | 2 | 2020 | 3684 | 0.030 |
Why?
|
RNA Probes | 1 | 2016 | 110 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2018 | 683 | 0.030 |
Why?
|
Cyclooxygenase 2 | 1 | 2019 | 596 | 0.030 |
Why?
|
Inflammation | 1 | 2016 | 10858 | 0.030 |
Why?
|
Clone Cells | 1 | 2020 | 1670 | 0.030 |
Why?
|
Receptors, Cell Surface | 2 | 2002 | 2815 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2021 | 713 | 0.030 |
Why?
|
Apolipoproteins A | 1 | 2016 | 94 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2002 | 1362 | 0.030 |
Why?
|
Dinoprostone | 1 | 2019 | 593 | 0.030 |
Why?
|
Macrophages | 3 | 2020 | 5775 | 0.030 |
Why?
|
Genome, Human | 2 | 2010 | 4442 | 0.030 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2021 | 778 | 0.030 |
Why?
|
U937 Cells | 1 | 2015 | 259 | 0.030 |
Why?
|
NF-kappa B | 1 | 2024 | 2495 | 0.030 |
Why?
|
Plasma Cells | 1 | 2019 | 597 | 0.030 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2016 | 175 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1117 | 0.030 |
Why?
|
Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2015 | 17 | 0.030 |
Why?
|
Oncogene Protein v-akt | 1 | 2015 | 130 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2019 | 1336 | 0.030 |
Why?
|
Antigens, CD | 2 | 2002 | 4025 | 0.030 |
Why?
|
X Chromosome Inactivation | 1 | 2017 | 229 | 0.030 |
Why?
|
Protein Transport | 1 | 2020 | 1939 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2019 | 872 | 0.030 |
Why?
|
Membrane Glycoproteins | 2 | 2002 | 3692 | 0.030 |
Why?
|
Osteonectin | 1 | 2014 | 33 | 0.030 |
Why?
|
Immunity | 1 | 2020 | 1001 | 0.030 |
Why?
|
Retinal Dehydrogenase | 1 | 2014 | 78 | 0.030 |
Why?
|
Arginase | 1 | 2015 | 81 | 0.030 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2016 | 361 | 0.030 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2016 | 533 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2019 | 1241 | 0.030 |
Why?
|
Down-Regulation | 2 | 2013 | 2927 | 0.030 |
Why?
|
Antigens, CD1 | 1 | 1997 | 434 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2019 | 752 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2015 | 463 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11859 | 0.030 |
Why?
|
Piperazines | 1 | 2024 | 2547 | 0.030 |
Why?
|
Steroids | 1 | 2019 | 934 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2002 | 2324 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3428 | 0.030 |
Why?
|
Glutamic Acid | 1 | 2019 | 1181 | 0.030 |
Why?
|
Genes, ras | 1 | 2016 | 656 | 0.030 |
Why?
|
Co-Repressor Proteins | 1 | 2014 | 190 | 0.030 |
Why?
|
England | 1 | 2015 | 533 | 0.030 |
Why?
|
Telomerase | 1 | 2018 | 749 | 0.030 |
Why?
|
Immunoglobulin G | 2 | 2019 | 4555 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 545 | 0.030 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2014 | 183 | 0.030 |
Why?
|
Young Adult | 4 | 2021 | 59858 | 0.030 |
Why?
|
Caspase 3 | 1 | 2015 | 731 | 0.030 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2016 | 657 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2022 | 4408 | 0.030 |
Why?
|
Disease Progression | 2 | 2020 | 13614 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2016 | 1524 | 0.020 |
Why?
|
Kinetics | 1 | 2020 | 6273 | 0.020 |
Why?
|
5' Untranslated Regions | 1 | 2013 | 255 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1673 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2013 | 412 | 0.020 |
Why?
|
Cerebellum | 1 | 2019 | 1519 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12975 | 0.020 |
Why?
|
RNA Splicing | 1 | 2016 | 902 | 0.020 |
Why?
|
Adolescent | 4 | 2021 | 88808 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3386 | 0.020 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2011 | 88 | 0.020 |
Why?
|
Phenotype | 4 | 2019 | 16714 | 0.020 |
Why?
|
Computational Biology | 1 | 2003 | 3563 | 0.020 |
Why?
|
PPAR alpha | 1 | 2012 | 177 | 0.020 |
Why?
|
Minor Histocompatibility Antigens | 2 | 2002 | 303 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2016 | 2062 | 0.020 |
Why?
|
Neuroglia | 1 | 2016 | 963 | 0.020 |
Why?
|
DEAD-box RNA Helicases | 1 | 2013 | 385 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2001 | 5503 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2013 | 1748 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2015 | 1131 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20135 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2023 | 81544 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2016 | 789 | 0.020 |
Why?
|
Prostate | 1 | 2018 | 1757 | 0.020 |
Why?
|
Lentivirus | 1 | 2013 | 518 | 0.020 |
Why?
|
Ovalbumin | 2 | 2002 | 674 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4133 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 3068 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2015 | 2677 | 0.020 |
Why?
|
Proteomics | 1 | 2003 | 3907 | 0.020 |
Why?
|
Lymph Node Excision | 1 | 2015 | 1262 | 0.020 |
Why?
|
Phosphorylation | 2 | 2013 | 8290 | 0.020 |
Why?
|
Neurosecretory Systems | 1 | 2011 | 223 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2016 | 897 | 0.020 |
Why?
|
Genetic Engineering | 1 | 2015 | 933 | 0.020 |
Why?
|
Genetic Variation | 1 | 2004 | 6611 | 0.020 |
Why?
|
Remission Induction | 1 | 2015 | 2413 | 0.020 |
Why?
|
Phylogeny | 1 | 2016 | 2838 | 0.020 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2011 | 332 | 0.020 |
Why?
|
DNA, Viral | 1 | 2015 | 2200 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 1997 | 1814 | 0.020 |
Why?
|
Calcium Channels | 1 | 2012 | 622 | 0.020 |
Why?
|
Fibroblasts | 1 | 2019 | 4161 | 0.020 |
Why?
|
Prostatectomy | 1 | 2016 | 1786 | 0.020 |
Why?
|
Heterochromatin | 1 | 2011 | 294 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2012 | 791 | 0.020 |
Why?
|
ras Proteins | 1 | 2013 | 1054 | 0.020 |
Why?
|
Luciferases | 1 | 2010 | 712 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2013 | 5879 | 0.020 |
Why?
|
Microglia | 1 | 2017 | 1371 | 0.020 |
Why?
|
Zinc Fingers | 1 | 2010 | 575 | 0.020 |
Why?
|
DNA Primers | 1 | 2012 | 2823 | 0.020 |
Why?
|
Reference Values | 1 | 2015 | 4909 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2010 | 873 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 1997 | 2206 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5019 | 0.020 |
Why?
|
Tight Junctions | 1 | 2010 | 332 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2007 | 351 | 0.020 |
Why?
|
Cytokines | 1 | 2022 | 7426 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2007 | 3796 | 0.020 |
Why?
|
Infant | 2 | 2019 | 36424 | 0.020 |
Why?
|
Cell Polarity | 1 | 2010 | 636 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 1407 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2844 | 0.020 |
Why?
|
Embryo, Nonmammalian | 1 | 2010 | 910 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39233 | 0.020 |
Why?
|
Podocytes | 1 | 2010 | 389 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4746 | 0.020 |
Why?
|
Fetus | 1 | 2013 | 1878 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4213 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2007 | 1304 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54804 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6840 | 0.020 |
Why?
|
Proteins | 1 | 2000 | 5994 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2015 | 22230 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1765 | 0.020 |
Why?
|
Karyotyping | 1 | 2007 | 1175 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 1966 | 0.020 |
Why?
|
Astrocytes | 1 | 2013 | 1353 | 0.020 |
Why?
|
Carcinoma in Situ | 1 | 2011 | 777 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2010 | 1102 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2013 | 2864 | 0.010 |
Why?
|
Retroviridae | 1 | 2007 | 845 | 0.010 |
Why?
|
Genes, Duplicate | 1 | 2004 | 31 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5365 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2001 | 10260 | 0.010 |
Why?
|
Receptors, Estradiol | 1 | 2003 | 18 | 0.010 |
Why?
|
Rabbits | 1 | 2010 | 4730 | 0.010 |
Why?
|
Software Validation | 1 | 2003 | 59 | 0.010 |
Why?
|
MEDLINE | 1 | 2003 | 119 | 0.010 |
Why?
|
Embryonic Stem Cells | 1 | 2010 | 1242 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10737 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9335 | 0.010 |
Why?
|
Cell Movement | 1 | 2014 | 5194 | 0.010 |
Why?
|
Cohort Studies | 2 | 2018 | 41677 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2011 | 2878 | 0.010 |
Why?
|
Muramidase | 1 | 2001 | 163 | 0.010 |
Why?
|
Gene Amplification | 1 | 2006 | 1088 | 0.010 |
Why?
|
Heart Transplantation | 1 | 2015 | 3301 | 0.010 |
Why?
|
Tetanus Toxin | 1 | 2000 | 46 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2011 | 2593 | 0.010 |
Why?
|
Drug Stability | 1 | 2000 | 289 | 0.010 |
Why?
|
Lymph Nodes | 2 | 2002 | 3457 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2012 | 3831 | 0.010 |
Why?
|
Gene Dosage | 1 | 2004 | 1211 | 0.010 |
Why?
|
Neurons | 1 | 2019 | 9521 | 0.010 |
Why?
|
United States | 2 | 2020 | 72918 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 65203 | 0.010 |
Why?
|
Drug Compounding | 1 | 2000 | 236 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 24272 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2010 | 3606 | 0.010 |
Why?
|
Rats | 1 | 2015 | 23718 | 0.010 |
Why?
|
Arteriosclerosis | 1 | 2003 | 1055 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2007 | 4112 | 0.010 |
Why?
|
Endocytosis | 1 | 2002 | 952 | 0.010 |
Why?
|
Zebrafish | 1 | 2010 | 3035 | 0.010 |
Why?
|
Adoptive Transfer | 1 | 2000 | 827 | 0.010 |
Why?
|
Disease | 1 | 2003 | 674 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 18075 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15882 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2003 | 1755 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2003 | 2718 | 0.010 |
Why?
|
Spleen | 1 | 2001 | 2294 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2011 | 4904 | 0.010 |
Why?
|
Lymphocytes | 1 | 2001 | 2602 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2000 | 2626 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2003 | 2689 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 1997 | 812 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1997 | 2270 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2000 | 1927 | 0.010 |
Why?
|
Thymus Gland | 1 | 1997 | 1259 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 36547 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12803 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2000 | 2210 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 2003 | 3743 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2007 | 26379 | 0.000 |
Why?
|
Bipolar Disorder | 1 | 2003 | 5128 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 2002 | 9237 | 0.000 |
Why?
|
Hypertension | 1 | 2003 | 8609 | 0.000 |
Why?
|
Algorithms | 1 | 2003 | 14065 | 0.000 |
Why?
|
Models, Biological | 1 | 1997 | 9446 | 0.000 |
Why?
|